Lir Life Sciences Valuation Multiples

Lir Life Sciences is valued at $3M as of November 2026. In the last fiscal year, Lir Life Sciences EBITDA was ($3M).

Lir Life Sciences Overview

About Lir Life Sciences

Lir Life Sciences Corp is focused on business of developing therapies across multiple treatment areas, with a focus on obesity and metabolic disorders. The Company is advancing transdermal formulations of GLP-1 combination therapies, with the goal of addressing key limitations of existing obesity treatments, including cost, accessibility, and patient adherence.


Founded

2018

HQ

Canada

Employees

N/A

Financials (Last FY)

Revenue: -
EBITDA: ($3M)

EV

$2M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Lir Life Sciences Financials

Lir Life Sciences reported last fiscal year revenue of - and negative EBITDA of ($3M).

In the same fiscal year, Lir Life Sciences generated ($3M) in EBITDA losses and had net loss of ($3M).


Lir Life Sciences P&L

In the most recent fiscal year, Lir Life Sciences reported revenue of - and EBITDA of ($3M).

Lir Life Sciences is unprofitable as of last fiscal year, with EBITDA margin of - and net margin of -.

See analyst estimates for Lir Life Sciences
Last FY2025202620272028
EBITDA($3M)($306K)
Net Profit($3M)($306K)

Financial data powered by Morningstar, Inc.

Lir Life Sciences Stock Performance

Lir Life Sciences has current market cap of $3M, and enterprise value of $2M.

Market Cap Evolution


Lir Life Sciences' stock price is $0.09.

Lir Life Sciences share price decreased by 5.8% in the last 30 days, and by 85.0% in the last year.

Lir Life Sciences has an EPS (earnings per share) of $-0.10.

See more trading valuation data for Lir Life Sciences
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2M$3M-7.3%-5.8%-9.8%-85.0%$-0.10

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Lir Life Sciences Valuation Multiples

Lir Life Sciences trades at (0.9x) EV/EBITDA.

See NTM and 2027E valuation multiples for Lir Life Sciences

Lir Life Sciences Financial Valuation Multiples

As of November 18, 2026, Lir Life Sciences has market cap of $3M and EV of $2M.

Lir Life Sciences has a P/E ratio of (1.0x).

Last FY2025202620272028
EV/EBITDA(0.9x)(8.1x)
EV/EBIT(1.0x)(8.1x)
P/E(1.0x)(8.5x)
EV/FCF(1.6x)(13.7x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Lir Life Sciences Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Lir Life Sciences Margins & Growth Rates

See estimated margins and future growth rates for Lir Life Sciences

Lir Life Sciences Growth Rates

25/2626/2727/2828/29
EBITDA Growth806%
EBIT Growth706%
Net Profit Growth807%
FCF Growth752%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Lir Life Sciences Competitors

Lir Life Sciences competitors include Mingteng International, Golden Age Exploration, Winshear Gold, Metalite Resources, Naughty Ventures, SIMSA, Eco Oro Minerals, Precomp Solutions, Cell Impact and Ceritech.

Most Lir Life Sciences public comparables operate across Metals & Mining.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Mingteng International$12M($974K)0.3x-(3.8x)-
Golden Age Exploration-($180K)--(12.8x)-
Winshear Gold-($1M)--(1.0x)-
Metalite Resources-($228K)--(9.7x)-
Naughty Ventures-$4M--0.1x-
SIMSA------
Eco Oro Minerals-$16M--0.5x-
Precomp Solutions$18M$797K0.3x-6.4x-

This data is available for Pro users. Sign up to see all Lir Life Sciences competitors and their valuation data.

Start Free Trial

Acquisitions by Lir Life Sciences

Lir Life Sciences has acquired 1 company to date.

Last acquisition by Lir Life Sciences was on November 10th 2025. Lir Life Sciences acquired LIR life Sciences for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Lir Life Sciences

LIR life Sciences
Description
LIR Life Sciences is a biopharmaceutical company developing treatments for obesity and metabolic disorders while expanding into additional therapy areas with next-generation drug candidates.
HQ CountryCanada
HQ City
Vancouver
Deal Date10 Nov 2025
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Lir Life Sciences acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Lir Life Sciences

When was Lir Life Sciences founded?Lir Life Sciences was founded in 2018.
Where is Lir Life Sciences headquartered?Lir Life Sciences is headquartered in Canada.
Who is the CEO of Lir Life Sciences?Lir Life Sciences' CEO is Ed Mills.
Is Lir Life Sciences publicly listed?Yes, Lir Life Sciences is a public company listed on Canadian Securities Exchange.
What is the stock symbol of Lir Life Sciences?Lir Life Sciences trades under SKNY ticker.
When did Lir Life Sciences go public?Lir Life Sciences went public in 2025.
Who are competitors of Lir Life Sciences?Lir Life Sciences main competitors include Mingteng International, Golden Age Exploration, Winshear Gold, Metalite Resources, Naughty Ventures, SIMSA, Eco Oro Minerals, Precomp Solutions, Cell Impact, Ceritech.
What is the current market cap of Lir Life Sciences?Lir Life Sciences' current market cap is $3M.
Is Lir Life Sciences profitable?No, Lir Life Sciences is not profitable.
How many companies Lir Life Sciences has acquired to date?As of November 2026, Lir Life Sciences has acquired 1 company.
What was the largest acquisition by Lir Life Sciences?None of the M&A deals Lir Life Sciences has completed have disclosed valuations.
What companies Lir Life Sciences acquired?Lir Life Sciences acquired LIR life Sciences.
In how many companies Lir Life Sciences has invested to date?Lir Life Sciences hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Lir Life Sciences

Lists including Lir Life Sciences

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial